1st Quarter - Report · 2026

Filing UUID: 09f4780a-8abc-4289-a0cf-09291ef258a8
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-17 14:44:14
Income (reported): $30,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

LMH STRATEGIC SOLUTIONS

Contact: ALANNA TEMME
Phone: +1 202-503-5189
Address: zip:20007, city:Washington, state:DC, street:2231 48th Street NW

Client

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Biopharmaceutical industry trade association.

State: DC
Country: US
Effective date: 2024-03-01

Issues lobbied + lobbyists

`PHA` — Pharmacy

Pharmaceutical Supply Chain. H.R.2213: Medical Supply Chain Resiliency Act. Issues related to the 340(b) program. H.R.1492/S.832: EPIC Act of 2025.

Lobbyists: ALANNA TEMME (covered position: Legislative Director, U.S. Representative Jon Porter); SOPHIE KHANAHMADI (covered position: Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions); MAXIMILIAN WALTER

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

`TRD` — Trade (domestic/foreign)

Issues related to USTR/trade.

Lobbyists: ALANNA TEMME; SOPHIE KHANAHMADI; MAXIMILIAN WALTER